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DAPCor hypothesized to be involved in staphylococcal IE pathogenesiswere tested. In parallel, the genotypic proﬁles of
all isolates, obtained by microarray, were analyzed by discriminant analysis of principal components (DAPC)(2).
No signiﬁcant differencewas observed between IE andbacteremia strains, regarding either phenotypic or genotypic
univariate analyses. However, the multivariate statistical tool DAPC, applied on microarray data, segregated IE and
bacteremia isolates: IE isolates were correctly reassigned as such in 80.6% of the cases (C-statistic 0.83, P b 0.001).
The performance of this model was conﬁrmed with an independent French collection IE and bacteremia isolates
(78.8% reassignment, C-statistic 0.65, P b 0.01). Finally, a simple linear discriminant function based on a subset of
8 geneticmarkers retained valuable performance both in study collection (86.1%, P b 0.001) and in the independent
validation collection (81.8%, P b 0.01).We here show that community-acquired IE and bacteremia S. aureus isolates
are genetically distinct based on subtle combinations of genetic markers. This ﬁnding provides the proof of concept
that bacterial characteristics may contribute to the occurrence of IE in patients with S. aureus bacteremia.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Infective endocarditis (IE)(1) is a severe complication occurring in 10–
25% of Staphylococcus aureus bacteremia (Kaasch et al., 2011; Seidl et al.,
2011). Despite a stagnation of the global incidence of IE over the past de-
cades in Europe and North America, the epidemiology has evolved, with
S. aureus being now the predominant causative pathogen (Murdoch
et al., 2009; Selton-Suty et al., 2012). Several host-related IE risk factors
have been identiﬁed, including drug use, congenital heart disease, or the
presence of cardiac prosthetic material (Hoen and Duval, 2013;
Moreillon and Que, 2004; Que and Moreillon, 2011). Still, approximately
30–50% of IE cases occur without any described risk factors (Hoen and
Duval, 2013), suggesting the probable involvement of bacterial features
in the occurrence of IE during bacteremia. Several in vitro and animal
studies have explored the role of diverse bacterial phenotypes in IE
(O'Brien et al., 2002; Piroth et al., 2008; Salgado-Pabón et al., 2013). The
few clinical studies attempting to conﬁrm the participation of such bacte-
rial determinants or speciﬁc multilocus sequence typing (MLST)(3) clonal
complex (CC)(4) yielded contradictory results (Nethercott et al., 2013;
Nienaber et al., 2011; Seidl et al., 2011; Xiong et al., 2009). To address
the question of a possible distinction between IE and bacteremia
S. aureus isolates, we conducted a systematic search for genotypic and
phenotypic differences between strictly deﬁned community-acquired
native-valve IE and bacteremia-related S. aureus isolates.2. Methods
2.1. Patients and strains
Two different sets of isolateswere analyzed. Theﬁrst one, designated
hereafter as the training set, included 126 S. aureus isolates (72 IE and 54
bacteremia) originating from a French national prospective multicenter
cohort, VIRSTA (Le Moing et al., 2015). Brieﬂy, patients with S. aureus
bacteremia and/or IE were included from 2009–2011 in eight teaching
hospitals across the French territory. Patients with community-
acquired and non-device related deﬁnite native-valve IE, with the pres-
ence of echocardiographic vegetation, were deﬁned as cases according
to the modiﬁed Duke criteria (Li et al., 2000). Patients meeting the
community-acquired “possible” or “excluded IE” deﬁnition, with nega-
tive requested trans-thoracic (TTE)(5) or trans-esophageal echocardiog-
raphy (TEE)(6), andnotmeetingpost-hospital criteria for IE at a 3-month
follow-up visit were deﬁned as bacteremia.
The second set of isolates, designatedhereafter as the test set, included
81 community-acquired methicillin-susceptible S. aureus (MSSA)(7)
bacteremia isolates collected during a prospective multicenter study
from 2006–2007 by 23 representative French hospital laboratories
(Grundmann et al., 2010) and 66 community-acquired MSSA deﬁnite IE
isolates collected during a French population-based survey in 2008
(Selton-Suty et al., 2012). These isolates had been previously genotyped
by microarray analysis (Tristan et al., 2012).All strains were thawed from −80 °C and grown on sheep-blood
agar plates at 37 °C.
2.2. DNA microarray assay
Bacterial DNA was extracted using commercial extraction kits
(Qiagen, Courtaboeuf, France) according to the manufacturer's recom-
mended protocol. The S. aureus microarray genotyping kit (Alere,
Jouy-en-Josas, France) used as well as related procedures and protocols
have been previously described in detail (Monecke et al., 2009). Brieﬂy,
the method uses multiplex PCR covering 332 alleles corresponding to
180 genes. For data interpretation, alleles of a same gene were pooled
as one genotypic marker to avoid redundancy; markers that were sys-
tematically positive or negative for all strains were excluded to avoid
background noise. A total of 138 genotypicmarkers were thus explored.
The assignation of isolates to MLST CCs was determined as previously
described (Monecke et al., 2009).
2.3. Phenotypic assays
To assess whether IE and bacteremia isolates could be distinguished
by phenotypic traits commonly thought to be relevant in S. aureus IE
pathophysiology, a subset of 28 isolates (14 IE and 14 bacteremia)
was selected, with stratiﬁcation on CCs to reﬂect their proportion in
the VIRSTA collection. The following phenotypes were assessed using
the previously described methods with or without modiﬁcation:
human neutrophil peptide-1 (hNP-1)(8) susceptibility (Xiong et al.,
2005), adherence to ﬁbrinogen and ﬁbronectin (Tristan et al., 2009),
bioﬁlm formation (Chavant et al., 2007), staphylokinase production
(Kwiecinski et al., 2010), platelet aggregation (O'Brien et al., 2002),
CD69 superantigen-induced expression (Lina et al., 1998), and adhesion
to and internalization by HUVEC(9) cells (Rasigade et al., 2011). Techni-
cal details are supplied in Text A.1.
2.4. Statistical analyses
2.4.1. Univariate analysis of microarray data
Univariate analysis was performed on theDNAmicroarray datawith
Fisher's exact test and with Bonferroni correction for multiple tests.
2.4.2. Principal component analysis
Principal component analysis (PCA)(10) was performed on the
strains' 138 microarray marker data (i) to display inter-strain genetic
variability within a strain collection, (ii) to deﬁne a set of factors that
clusters strains on the factorial map of the PCA and (iii) to compare
the genetic variability of two different strain groups (IE andbacteremia).
2.4.3. Discriminant analysis of principal components (DAPC)
DAPC is a linear discriminant analysis method with a built-in dimen-
sionality reduction ability with proven performance for the analysis of
Table 1
Phenotypic characteristics of IE and bacteremia isolates.
Phenotypes Mean ± SD Pa
IE (n = 14) Ba (n = 14)
Fibrinogen binding (% of binding) 51.7 ± 10.22 47.7 ± 10.14 0.611
Fibronectin binding (% of binding) 45.7 ± 7.31 47.4 ± 5.82 0.826
Endothelial cell adhesion (% of binding) 93.9 ± 28.80 90.1 ± 33.12 0.853
Endothelial cell internalization
(% of internalization)
133.1 ± 13.23 140.4 ± 19.45 0.483
Bioﬁlm production (BFI) 12.5 ± 7.21 12.3 ± 7.41 0.968
hNP-1 resistance
(% of surviving bacteria)
35.3 ± 9.27 36.6 ± 18.25 0.810
Staphylokinase production
(kinetics slope)
0.13 ± 0.031 0.21 ± 0.045 0.130
Platelet aggregation
(lag time in minutes)
2.5 ± 2.42 2.2 ± 1.57 0.757
Superantigenic properties
(ﬂuorescence arbitrary intensity)
694.6 ± 133.28 631.8 ± 158.83 0.764
Abbreviations: SD, standard deviation; IE, infective endocarditis; Ba, bacteremia; and BFI,
bioﬁlm forming index.
a Statistical signiﬁcance was calculated for each gene or allele with the two-tailed
Fisher's exact test.
Table 2
Distribution of clonal complexes (CC) in the two populations.
Clonal complex (CC) IE (%) n = 72 Bacteremia (%) n = 54 Pa
CC5 13 (18.1) 12 (22.2) 0.65
CC8 7 (9.7) 4 (7.4) 0.76
CC15 11 (15.3) 2 (3.8) 0.04
CC30 5 (6.9) 7 (13) 0.36
CC45 10 (13.9) 5 (9.3) 0.58
CC398 6 (8.3) 2 (3.8) 0.46
Othersb 18 (25) 22 (40.7) 0.08
Abbreviations: IE, infective endocarditis.
a Statistical association was estimated using Fisher's exact test.
b CC1, CC7, CC9, CC12, CC22, CC25, CC59, CC88, CC97, CC101, CC121, CC152, CC182, CC188.
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2015). Brieﬂy, DAPC was used to (i) identify the optimal number of prin-
cipal components (PCs) to use in DAPC to avoid over discrimination; (ii)
ﬁnd the discriminant function (DF)(11) that best separates the two IE
and bacteremia groups and calculate individual membership probability
and (iii) identify the individual and/or combination markers derived
from the DF allowing the discrimination between the IE and bacteremia
groups.
The indicator of discrimination performance was deﬁned by the as-
signment success rate as the ratio of the number of correctly assigned
isolates to the total number of isolates. Cross-validation was performed
using 70% of the training collection as an evaluation set; variation in the
assignment success rate with the number of retained PCs was assessed
using the remaining 30% isolates. The assignment success rate of the
DAPC was calculated, assuming that a strain was correctly assigned to
its original group if its membership probability was higher than 0.50.
The contribution of the original variables (i.e., genotypic markers) to
the DF was then calculated to identify the most contributing markers.
To investigate the robustness of the DAPC model trained on the
VIRSTA collection, the samemodel was applied to the 66 IE and 81 bac-
teremia isolates of the independent test set.
A DF (without prior PC analysis) was then computed based on the
eight most contributing markers with respect to the weight of each
marker and was adjusted to yield a decision threshold equal to zero.
C-statistics and Chi2 P-values of association between observed and
predicted values were computed for all models (DAPC and DF).
All analyses were performed with R 3.0.2 software (R development
Core Team 2013) using the ade4 (Dray and Dufour, 2007) and adegenet
libraries (Jombart and Ahmed, 2011).
2.5. Ethics
The French National Ethics Committee “Comité de Protection des
Personnes Sud-Méditerrannée IV” approved the study. The VIRSTA
study is registered in the European Clinical Trials Database (EUDRACT)
(number: 2008-A00680-55). Informed written consent was obtained
from all patients.
3. Results
A total of 126 community-acquired isolates, collected from 72 IE and
54 bacteremia cases, were available. All 122 MSSA and 4 methicillin-
resistant S. aureus isolates, were analyzed with the DNA microarray
kit. Phenotypes were explored on a subset of 28 isolates (14 IE and 14
bacteremia) selected with stratiﬁcation on MLST clonal complex to re-
ﬂect their proportion in the VIRSTA collection (see text in Section 2.3).
3.1. In vitro phenotypes do not discriminate IE isolates from bacteremia
isolates
Diverse bacterial phenotypes like S. aureus ability to bind ﬁbrinogen
and ﬁbronectin (Piroth et al., 2008; Que and Moreillon, 2011; Xiong
et al., 2009), resistance to microbicidal peptides (Fowler et al., 2000,
2004; Xiong et al., 2009; Yeaman et al., 1997), bioﬁlm production
(Mohamed et al., 2004; Seidl et al., 2011), and the formation of
platelet-bacteria thrombi on the valve surface (Heilmann et al., 2004;
O'Brien et al., 2002) have been described as critical in IE occurrence.
Thus, adhesion to the extracellular matrix (ﬁbrinogen and ﬁbronectin)
and endothelial cells, as well as internalization by endothelial cells, re-
sistance to themicrobicid human neutrophil peptid, bioﬁlm production,
and induction of platelet aggregation were thus tested. Moreover, be-
cause staphylokinase production activates plasminogen into plasmin,
which in turn degrades ﬁbrin clots, we hypothesized that its production
may interfere with platelet-bacteria thrombus formation at IE initiation
(Kwiecinski et al., 2013). Given the evidence that enterotoxin C could
play a role in IE (Salgado-Pabón et al., 2013), CD69 cell activation,reﬂecting the superantigen activity of our strains, was also tested
(Lina et al., 1998). Considering each of the tested phenotypes, our re-
sults showed no difference between the two groups and thus revealed
that IE and bacteremia isolates could not be discriminated based on
such features (Table 1, Fig A.1).
3.2. IE and bacteremia isolates belong to a wide variety
of genetic backgrounds
The 126 analyzed isolates fell into 21 differentMLST CCs assigned by
the DNA microarray (Table 2), reﬂecting the wide genetic diversity in
the IE isolates (16 different CCs) as well as in the bacteremia isolates
(16 different CCs). CC5 was the predominant lineage in both the IE
(n = 13, 18.1%) and the bacteremia (n = 12, 22.2%) groups. Nearly
50% of IE isolates were represented by only three CCs (CC45, CC5 and
CC15) (Table 2). CC30, which has been previously associated with IE
(Nienaber et al., 2011), and CC398, which has been described as an
emerging lineage in IE (Tristan et al., 2012), accounted for only 6.9%
(n = 5) and 8.3% (n = 6) of IE isolates, respectively. None of the CCs
was speciﬁcally associated with either IE or bacteremia, except CC15,
which, although infrequent, was slightly more prevalent in IE than in
bacteremia (15.3% vs. 3.8%, respectively) (P = 0.04, two-tailed Fisher's
exact test) (Table 2).
3.3. Univariate analysis and principal component analysis do not discrimi-
nate IE isolates from bacteremia isolates
In a ﬁrst step of assessingwhether speciﬁc virulence factors could be
associatedwith IE, univariate analysis was performed from138markers
detected by DNAmicroarray data (see text in Section 2.2). Known viru-
lence factors encoding genes, such as adhesins, enterotoxins, exfoliatins
Table 3
Frequency of the genes detected byDNAmicroarray in S. aureus IE and bacteremia isolates.
Gene or allele IE isolates (%) n = 72 Bacteremia isolates (%) n = 54 P-value(a)
Adhesin encoding genes
fnbA 72 (100) 54 (100) 1.000
fnbB 65 (90.3) 46 (85.2) 0.416
clfA 72 (100) 54 (100) 1.000
clfB 72 (100) 54 (100) 1.000
cna (b) 32 (44.4) 26 (48.1) 0.718
spa 72 (100) 54 (100) 1.000
sdrC 72 (100) 53 (98.1) 0.432
sdrD 56 (77.8) 43 (79.6) 0.834
bbp 66 (91.7) 49 (90.7) 1.000
ebpS 72 (100) 54 (100) 1.000
map/eap 71 (98.6) 48 (88.9) 0.042
Toxin encoding genes
eta 1 (1.4) 1 (1.9) 1.000
etb 0 (0) 1 (1.9) 0.433
tst1 7 (9.7) 8 (14.8) 0.416
sea 12 (16.7) 5 (9.3) 0.301
seb 6 (8.3) 8 (14.8) 0.272
sec 10 (13.9) 2 (3.7) 0.070
sed 7 (9.7) 5 (9.3) 1.000
see 0 (0) 0 (0) 1.000
seg 34 (47.2) 35 (64.8) 0.074
seh 2 (3.2) 4 (7.4) 0.400
sei 34 (47.2) 35 (64.8) 0.072
sej 7 (9.7) 5 (9.3) 1.000
lukSF-PV 0 (0) 4 (7.4) 0.031
hla (c) 71 (98.6) 49 (90.7) 1.000
hlb123 (d) 48 (66.7) 44 (81.5) 0.074
func_hlb (e,f) 9 (12.5) 9 (16.7) 0.601
Other putative virulence factors encoding genes
icaA 72 (100) 54 (100) 1.000
chp (g) 46 (63.9) 32 (59.3) 0.453
Regulation encoding genes
agrI 33 (45.8) 22 (40.7) 0.587
agrII 28 (38.9) 17 (31.5) 0.446
agrIII 8 (11.1) 11 (20.4) 0.213
agrIV 3 (4.2) 4 (7.4) 0.462
(a) P-values are calculated for each gene or allele with a two-tailed Fisher's exact test.
Bonferronni correction was applied (signiﬁcant p-value ≤ 0.002).
(b) 2 isolates (1IE, 1 Ba), (c) 5 isolates (1 IE, 4 Ba), (f) 12 isolates (6 IE, 6 Ba) and (g) 3 isolates
(3 IE) were excluded because of ambiguous results.
(d) hlb123 represents hlb encoding gene alleles detected by one of the probes 1,2,3.
(e) func_hlb accounts for the hlb functional encoding gene.
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icantly associated with IE in univariate analysis with Bonferroni correc-
tion (Table 3). To explore the possibility that multiple genetic markers
contribute to the discrimination between IE and bacteremia isolates,
principal component analysis was performed on microarray data of
the 126 strains. Projection on the ﬁrst factorial plan of the IE and bacter-
emia groups did not lead to any obvious clustering (Fig. 1), conﬁrming
the close genetic relationship between IE and bacteremia strains. All in
all, univariate and PCA statisticalmethods did not evidence clear genetic
distinctions between IE and bacteremia strains.
3.4. Combining genotypic markers discriminates IE from
bacteremia isolates
We used themultivariate statistical method DAPC to generate a dis-
criminant function allowing the discrimination between several popu-
lations (Jombart et al., 2010). Cross-validation showed an optimum
number of 30 PCs (93.7% of the total variance), and subsequent DAPC
was therefore performed with 30 PCs. The distribution of the DF scores
for IE and bacteremia isolates is shown in Fig. 2.
TheDAPCmodel basedon these 30PCs yielded a reassignment success
rate of 80.6% and 68.5% for IE (58/72) and bacteremia isolates (38/54), re-
spectively (C-statistic 0.83, P b 0.001). The variability of the assignment
success rates between CC groups was very low (CC5, 72.0%; CC8, 81.8%;CC15, 76.9%; CC30, 66.7%; CC45, 73.3%; all contingency χ2, P N 0.64), sug-
gesting that theCCgroups did not affect thepower of theDF.Nearly half of
IE isolates (n = 33/72, 45.8%) were assigned to the IE group with a high
membership probability (N0.80) and few IE isolates (n = 7/72) showed
an individual membership probability below 0.40 (Fig A.2A).
3.5. Validation of the statistical model on an independent collection
The robustness of the statisticalmodelwas tested on the independent
set of 81 bacteremia and 66 deﬁnite-IE isolates (see Section 2.1). The as-
signment success rate of IE isolates remained as high as 78.8% (52/66 IE
isolates) whereas it decreased to 44.4% for bacteremia isolates (36/81
bacteremia isolates) (C-statistic 0.65, P b 0.01) (Fig A.2B), probably due,
at least in part, to the fact that IE had not been strictly ruled out by sys-
tematic TTE/TEE in this collection of bacteremia cases, contrary to the
VIRSTA collection (Grundmann et al., 2010). Plus, the proportion of IE
isolates assigned with a high membership probability (N0.80) was simi-
lar in the training and test sets (43.9% vs. 45.8%) (Fig A.2B), corroborating
the robustness of this combination of markers to distinguish IE from
bacteremia isolates.
3.6. An eight-marker linear model retains good performance in discriminat-
ing IE isolates
The DAPC model, which allows the determination of the markers
most contributing to the DF (Fig. 3), revealed that a subset of eight
markers, namely, ermA, sea, seb, sec, sel, setC/selx, hlb123 and Q2YUB3,
could be retained in a simpliﬁedmodel. Of note, the ermA product con-
fers resistance to the macrolide antibiotic family; sea, seb, sec and sel
encode enterotoxins A, B, C and L, respectively; setC/selx encodes a
superantigen-like protein; Q2YUB3 encodes a putative efﬂux protein;
and hlb123 represents three alleles of the β-hemolysin-encoding gene
detected by DNA microarray.
The analysis performed on this limited number of markers, whose
normalized weights are given in Table 4, exhibited a reassignment suc-
cess rate of IE isolates as high as 86.1% (62/72) in the training set and
81.8% (54/66) in the test set.
4. Discussion
Understanding the pathophysiology of S. aureus IE and the participa-
tion of both the host and the bacteria is a major challenge in the ﬁeld of
infectious diseases. The previous identiﬁcation of several bacterial pheno-
types associated with IE in in vitro studies or in animal models using iso-
genic strains (Salgado-Pabón et al., 2013) (Que, 2005) (Piroth et al., 2008)
had raised the hope of determining phenotypic characteristics contribut-
ing to IE occurrence. In our collection of well-deﬁned native-valve IE and
bacteremia isolateswith both temporal and geographicalmatching, possi-
ble discrimination based on phenotypic characteristics or single genetic
features was excluded. However, we showed that the genetic proﬁle of
the causative strain obtained by DNAmicroarray, allowed the discrimina-
tion of S. aureus IE from S. aureus bacteremia isolates.
Our results showed no signiﬁcant difference between IE and bacter-
emia isolates regarding bacterial phenotypes like adherence to extra-
cellular matrix components (ﬁbrinogen, ﬁbronectin), adhesion and in-
ternalization into endothelial cells, bioﬁlm production or susceptibility
to microbicidal peptide hNP-1. Furthermore, we tested phenotypes
that are likely to be involved in IE but that they had never been explored
before on a large series of clinical isolates. For instance, given the evi-
dence that enterotoxin C could play a role in IE (Salgado-Pabón et al.,
2013), we tested the superantigenic activity of our strains. Since
staphylokinase production activates plasminogen into plasmin, which
in turn degrades ﬁbrin clots, we hypothesized that its production may
interfere with the platelet-bacteria thrombi at IE initiation. However,
neither CD69-cell activation reﬂecting the superantigenic properties of
S. aureus strains nor staphylokinase production led to any signiﬁcant
Fig. 1. First factorial plan of principal component analysis (PCA) of the DNAmicroarray data of the VIRSTA isolates. Each strain was plotted on the two ﬁrst principal components. Each IE
(IE) and bacteremia (Ba) strain is represented by a blue and red dot, respectively; the centroid and variability of IE and bacteremia groups are displayed by blue and red ellipses,
respectively.
Fig. 2. Distribution of VIRSTA isolates according to their individual DF scores. IE (red) and
bacteremia (blue) isolates are plotted according to their DF scores (X-axis); the density of
isolates with the same DF score is represented on the Y-axis.
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rule out the possibility of a single speciﬁc bacterial phenotype responsi-
ble for the occurrence of IE in the course of S. aureus bacteremia. These
results are in line with previous studies that either reported no signiﬁ-
cant differences between IE isolates and non-IE isolates comparing
their ability to adhere or to be internalized into endothelial cells or to
produce bioﬁlm (Seidl et al., 2011; Xiong et al., 2009), either led to con-
ﬂicting results in clinical strain studies (Xiong et al., 2009; Ythier et al.,
2010). Importantly, our results do not preclude the signiﬁcance of cer-
tain phenotypes that have been clearly individually established
in vitro or in animal models under experimental conditions optimizing
the function of speciﬁc determinants (i.e., heterologous expression in
Lactococcus lactis) (Que, 2005).
Considering the isolates' genetic background, univariate analysis did
not reveal any speciﬁcMLST CC or genotypicmarkers associatedwith IE
isolates compared with strictly deﬁned bacteremia isolates (Tables 2 &
3). These ﬁndings are consistentwith a study by Tristan et al. comparing
IE and bacteremia isolates (Tristan et al., 2012). Of note, in works by
Nethercott et al., CC12 and CC20 were associated with IE isolates com-
pared with bacteremia and skin and soft tissue infections (SSTI)(12) iso-
lates (Nethercott et al., 2013). Similarly, CC30 in Nienaber's study, and
several adhesins and enterotoxins in Rasmussen's study were associat-
ed with IE compared with skin and soft-tissue infection isolates and
nasal carriage isolates, respectively, but not with bacteremia isolates
(Nienaber et al., 2011; Rasmussen et al., 2013). Given the comparator
groups of these studies, we hypothesize that these data reveal the role
Fig. 3.Contributionof each genotypicmarker to theDF. Upon visual inspection of theplot ofmarker contributions, an inﬂection point (horizontal line) located after theeightmost contributing
markers was identiﬁed, suggesting that markers with a lower contribution could be of little beneﬁt to the performance of the model.
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tion. Taken together, our results indicate that no single speciﬁc bacterial
phenotype or genotypicmarker seems to be individually responsible for
the occurrence of IE in the course of S. aureus bacteremia.
Turning to amore powerfulmultivariatemodel usingDNAmicroarray
assay data, we showed that DAPCwas able to discriminate IE frombacter-
emia isolateswith robust performance, evenwhen applied to an indepen-
dent collection. Finally, a simple linear DF based on a subset of 8 markers
showed valuable performance both in the study and in independent val-
idation collection. This ﬁnding clearly uncovers subtle genetic differences
between IE and bacteremia isolates. This is in linewith complex eukaryot-
ic phenotypes, which are presumed to result from the additive effects and
interactions among multiple causative alleles, for which individual effect
varies from imperceptible to signiﬁcant, rather than to monogenic traits
(Marian, 2012). Of note, ﬁve of the eight markers retained in the ﬁnal
model are superantigens or superantigen-like proteins (Fig. 3), some of
them being positively associated with IE, others negatively (Table 4),
whichmay explain that the overall superantigen activity did not differ be-
tween IE and bacteremia isolates (Table 1 and Fig A.1). Moreover, theTable 4
Predictive model for infective endocarditis based on
eight genetic markers of Staphylococcus aureus.
Marker Weight a
setC/selx 1.000
sea 0.620
seb −0.510
hlb123 −0.463
Q2YUB3 −0.460
ermA 0.442
sec 0.412
sel 0.412
Constant −0.527
a Presence or absence of the genetic markers coded
as 1 or 0, respectively. S. aureus isolates with a weight
sum of N0 are assigned to the infective endocarditis
group.functional role of ermA, a macrolide-resistance gene, or Q2YUB3, a puta-
tive efﬂux protein, in causing IE remains elusive. These associations may
well be surrogate markers of genome rearrangements affecting, for
instance, core-genome expression or causing epigenetic alterations
(Borrell and Gagneux, 2011), rather than causative elements.
To conclude,we here provide the proof of concept that IE andbacter-
emia isolates are distinct based on subtle genetic differences. This drives
forward the understanding of S. aureus IE andmay open up to promising
use of such combinations of genetic markers to predict the risk for IE.
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